Detalhe da pesquisa
1.
Immunogenicity and safety of porcine circovirus-free human rotavirus vaccine in healthy infants: a phase III, randomized trial.
J Infect Dis
; 2020 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365189
2.
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children.
J Infect Dis
; 208(4): 544-53, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847058
3.
Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule.
Hum Vaccin Immunother
; 20(1): 2342630, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687024
4.
Molecular epidemiology of pneumococcal carriage in children from Seville, following implementation of the PCV13 immunization program in Andalusia, Spain.
Enferm Infecc Microbiol Clin (Engl Ed)
; 42(4): 172-178, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085445
5.
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring.
Influenza Other Respir Viruses
; 17(3): e13098, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991538
6.
Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review.
Hum Vaccin Immunother
; 19(1): 2191575, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076111
7.
Factors influencing HPV knowledge and vaccine acceptability in parents of adolescent children: results from a survey-based study (KAPPAS study).
Hum Vaccin Immunother
; 18(1): 2024065, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35103571
8.
Brand-Specific Enhanced Safety Surveillance Study of GSK's Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season.
Infect Dis Ther
; 11(1): 463-483, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961900
9.
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults.
Hum Vaccin Immunother
; 18(1): 1981085, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614379
10.
Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
Drug Saf
; 44(12): 1375-1390, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694589
11.
Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.
Drug Saf
; 43(3): 265-279, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31884676
12.
Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons.
Lancet Child Adolesc Health
; 2(5): 338-349, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30169267
13.
[Bacterial etiology of acute otitis media in Spain in the post-pneumococcal conjugate vaccine era]. / Etiología bacteriana de la otitis media aguda en España en la era de la vacuna neumocócica conjugada.
An Pediatr (Barc)
; 85(5): 224-231, 2016 Nov.
Artigo
em Espanhol
| MEDLINE | ID: mdl-26969247
14.
A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months.
Hum Vaccin Immunother
; 10(7): 1959-68, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424805